CXCL13 and type 1 diabetes mellitus: In the autoimmune Non-Obese Diabetic (NOD) T1DM mouse model, CXCL13 and its cognate receptor, CXCR5, were highly expressed during the development of ELSs, especially in the early onset of diabetes (100).